Jean‐Léon Lagrange

70 Gy Versus 80 Gy in Localized Prostate Cancer: 5-Year Results of GETUG 06 Randomized Trial

V. Beckendorf, S. Guérif, É. Le Prisé et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 447 citations

Urology, Surgical Oncology, Genitourinary Cancer +8

Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial

C. Carrié, Ali Hasbini, Guy de Laroche et al. · The Lancet Oncology · 2016 · 356 citations

Urology, Surgical Oncology, Salvage Radiotherapy +8

Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial

C. Carrié, Nicolas Magné, Patricia Burban-Provost et al. · The Lancet Oncology · 2019 · 239 citations · Full text

Surgical Oncology, Urology, Radiation Therapy +8

Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial

Karim Fizazi, Laura Faivre, F. Lesaunier et al. · The Lancet Oncology · 2015 · 236 citations

Urology, Getug 12, Genitourinary Cancer +8

Sarcoma after Radiation Therapy: Retrospective Multiinstitutional Study of 80 Histologically Confirmed Cases

Jean‐Léon Lagrange, A. Ramaioli, Marie‐Christine Chateau et al. · Radiology · 2000 · 202 citations